Analyst Ratings for Puma Biotechnology (PBYI)
PBYI Rating Summary
PBYI Price Target Summary
- Highest: $4.00 (TD Cowen)
- Lowest: $4.00 (TD Cowen)
- Average: $4.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$4.00 (-18%)
* Over Last 12-Mos
Rating Score: 3.3 / 10
Percentile Rank: 30%
Rating Score: 3.3 / 10
Percentile Rank: 30%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/28/2021 | Citi | Yigal Nochomovitz | Upgrade | Buy (Neutral) |
11.00 (N/A) |
6.82 (4.88) |
-28.45% | Details |
| 6/25/2020 | BofA Securities | Ying Huang | New Coverage | Underperform (N/A) |
9.00 (N/A) |
11.39 (4.88) |
-57.16% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
